Table 2.
Variable (%)a,b | Median (IQR) | p valuec |
---|---|---|
CD4+IL-2+ | −0.17 (−1.98, 2.02) | 0.93 |
CD4+MIP1β+ | 0.53 (−2.05, 2.38) | 0.81 |
CD4+MIP1β+IL-2+ | −0.09 (−0.46, 0.49) | 0.91 |
CD4+PERF+ | −0.12 (−2.85, 2.21) | 0.79 |
CD4+TNF-α+ | −0.56 (−2.27, 1.21) | 0.31 |
CD4+PERF+TNF-α+ | −0.32 (−0.76, 0.79) | 0.69 |
CD8+IL-2+ | 0.56 (−2.31, 1.94) | 0.85 |
CD8+MIP1β+ | 0.58 (−2.60, 4.32) | 0.35 |
CD8+MIP1β+IL-2+ | 0.14 (−0.79, 1.44) | 0.53 |
CD8+PERF+ | −0.24 (−3.59, 3.93) | 0.65 |
CD8+TNF-α+ | −0.69 (−2.79, 2.62) | 0.62 |
CD8+PERF+TNF-α+ | −0.37 (−1.45, 1.66) | 0.77 |
N = 49.
Subsets, measured by flow cytometry, are expressed as a percentage of the parent CD4+ or CD8+ B cell population.
Wilcoxon matched pairs signed-rank tests.